<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="124308">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01791673</url>
  </required_header>
  <id_info>
    <org_study_id>EYEMUST-3</org_study_id>
    <nct_id>NCT01791673</nct_id>
  </id_info>
  <brief_title>Circular Cyclocoagulation Using HIFU With EYEOP1 Device in Glaucoma Patients</brief_title>
  <official_title>Efficacy and Safety of Circular Cyclocoagulation Using High Intensity Focused Ultrasound With EYEOP1 Device in Glaucoma Patients. Prospective Multicenter Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>EyeTechCare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>EyeTechCare</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <authority>France: Institutional Ethical Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate the effectiveness and the safety of the cyclocoagulation
      using HIFU in glaucoma patients
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Anticipated">April 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Success rate : Proportion of eyes that achieve an IOP of &gt; 5 mmHg and &lt;21 mmHg or an IOP reduction &gt; 20%</measure>
    <time_frame>up to 12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Success rate = complete success rate (achieved without ocular hypotensive medication) + qualified success (achieved with ocular hypotensive medication)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Average change in IOP (mm Hg)</measure>
    <time_frame>3, 6 and 12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage change in IOP from baseline</measure>
    <time_frame>3, 6 and 12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average change in glaucoma hypotensive medications</measure>
    <time_frame>3, 6 and 12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of device and procedure-related complications during follow-up</measure>
    <time_frame>3, 6 and 12 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>Ultrasonic Circular cyclocoagulation using HIFU</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasonic Circular Cyclocoagulation with EYEOP1 Device</intervention_name>
    <arm_group_label>Ultrasonic Circular cyclocoagulation using HIFU</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary Open-angle glaucoma included pseudo-exfoliative glaucoma and pigmentary
             glaucoma

          -  IOP &gt; 21 mm Hg on glaucoma medications, and indicated for filtering glaucoma surgery

          -  Patient must be aged 18 years and more

          -  No previous cyclophotocoagulation procedure in the eye

          -  No previous laser treatment in the eye during the 3 months before HIFU procedure

        Exclusion Criteria:

          -  History of previous glaucoma surgery with implantation of glaucoma drainage device in
             the study eye

          -  History of ocular or retrobulbar tumor

          -  retinal detachment, choroidal hemorrhage or detachment

          -  Ocular infectious diseasee within 14 days before HIFU procedure
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe DENIS, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Croix Rousse University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Dijon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain BRON, MD</last_name>
      <email>Alain.bron@chu-dijon.fr</email>
    </contact>
    <investigator>
      <last_name>Alain BRON, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Michallon University Hospital</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florent APTEL, MD</last_name>
      <email>faptel@chu-grenoble.fr</email>
    </contact>
    <investigator>
      <last_name>Florent APTEL, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Huriez University Hospital</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-François ROULAND, MD</last_name>
      <email>jean-francois.rouland@chru-lille.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-François ROULAND, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Croix Rousse University Hospital</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe DENIS, MD</last_name>
      <email>philippe.denis@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>Philippe DENIS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HIA - Val de Grace Hospital</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Paul RENARD, MD</last_name>
      <email>pr_renard@yahoo.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Paul RENARD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <lastchanged_date>February 13, 2013</lastchanged_date>
  <firstreceived_date>February 13, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Glaucoma</keyword>
  <keyword>Cyclocoagulation</keyword>
  <keyword>HIFU - High Intensity Focused Ultrasound</keyword>
  <keyword>Ciliary Body</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
